Explainer · August 9, 2026 · 5 min · By Fletcher Imafidon
Why Mohs Surgery Takes All Day: The Lab Work Happening Between Stages
Patients often wait hours in the office while their surgeon removes what looks like a small piece of skin. The reason lies in a tissue processing workflow that most people never see.
One of the most common complaints about Mohs micrographic surgery has nothing to do with pain or scarring. It is the waiting. A patient arrives at 8 a.m. for a lesion the size of a pencil eraser and may not leave until mid afternoon. Understanding what happens during those gaps, when the patient sits bandaged in a waiting room, makes the timeline far less mysterious and, for many people, far less frustrating.
The core promise of Mohs is complete margin evaluation. Standard excision sends tissue to an outside lab, where a pathologist examines thin vertical slices, a method sometimes compared to checking a few slices of a bread loaf. That approach samples roughly 1 to 2 percent of the actual surgical margin. Mohs surgery instead examines close to 100 percent of the peripheral and deep margin of each tissue layer removed. That difference in coverage is the mechanism behind the technique's high cure rates for many skin cancers, often cited around 97 to 99 percent for previously untreated basal cell carcinoma. Achieving it requires real time laboratory work, and that work takes time.
Stage one: removal and mapping. After numbing the area with local anesthetic, the surgeon removes the visible tumor plus a thin rim of surrounding skin, typically 1 to 2 millimeters. Before the tissue leaves the room, the surgeon scores small notches in it and draws a corresponding map, a diagram that records exactly how the specimen was oriented on the patient's body. This map is the navigation system for everything that follows. If cancer cells appear at one edge under the microscope, the map tells the surgeon precisely which clock position on the wound needs another pass, and only that position.
Stage two: the frozen section lab. The removed tissue goes to an on site laboratory, usually a few steps from the procedure room. A histotechnician divides the specimen, inks the edges with colored dyes keyed to the map, and flattens the tissue so the entire outer edge and undersurface lie in one plane. This flattening step, called en face processing, is what allows the whole margin to be examined rather than a sample of it. The tissue is then frozen in a cryostat, sliced into sections a few microns thick, mounted on glass slides, and stained. Even in an efficient lab this cycle typically takes 20 to 60 minutes per stage, and complex or fatty tissue can take longer because fat freezes and sections poorly.
Stage three: the surgeon reads the slides. In Mohs surgery, the operating physician is also the pathologist for the case. This dual role is a defining feature of the technique and part of its fellowship training pathway. The surgeon examines every slide, checking the inked margins for tumor cells. If the margins are clear, the case moves to repair. If any margin shows residual cancer, the surgeon marks the exact location on the map, returns to the patient, re numbs the area if needed, and removes another thin layer only where the tumor persists. Then the entire lab cycle repeats.
Why some cases need one stage and others need four. Skin cancers do not grow as neat spheres. Basal cell carcinoma in particular can send finger like extensions under clinically normal appearing skin, especially in recurrent tumors, aggressive histologic subtypes such as morpheaform or infiltrative patterns, and tumors on the nose, ears, and eyelids. What looks like a 6 millimeter lesion on the surface can have roots extending well beyond the visible edge. Each additional stage means another round of excision, processing, and microscopic review. Most cases clear in one to two stages, but three or more is not unusual for infiltrative tumors, and none of it can be predicted with certainty beforehand.
What patients can realistically do with this information. First, plan for a full day. Bring food, water, reading material, and any regular medications. Second, do not interpret a long wait as a sign that something went wrong. Multiple stages usually mean the tumor was more extensive under the skin than it appeared, which is exactly the scenario Mohs is designed to catch. Third, understand that the final wound may be larger than the original spot. The surgeon is chasing the true footprint of the tumor, not the visible one, and repair options are discussed only after the last stage confirms clear margins.
A note on repair timing. Once margins are clear, the surgeon and patient decide how to close the wound: direct suturing, a flap, a graft, or in some cases healing by secondary intention. Because reconstruction happens only after microscopic confirmation, tissue is never rearranged over an area that might still harbor cancer, which is another quiet advantage of the same day workflow.
The hours spent in the waiting room are not idle time in the process. They are the process. Every delay corresponds to tissue being inked, frozen, sectioned, stained, and read, all in service of removing the least normal skin possible while confirming, under a microscope, that the cancer is gone before a single repair stitch is placed.
Related reading: What Actually Happens to Your Tissue Between Mohs Stages.
Further reading: Mohs micrographic surgery in the surgical treatment paradigm of melanoma in situ and invasive melanoma: A clinical review of treatment efficacy and ongoing controversies (J Am Acad Dermatol 2024); Mohs Micrographic Surgery for Melanoma: Evidence, Controversy, and a Critical Review of Excisional Margin Guidelines (Dermatol Clin 2023); Comparison of Modern Super Wide Field Microscopy Systems in Mohs Surgery (J Drugs Dermatol 2021).